Literature DB >> 7939685

c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.

A E Grigoriadis1, Z Q Wang, M G Cecchini, W Hofstetter, R Felix, H A Fleisch, E F Wagner.   

Abstract

Mice lacking the proto-oncogene c-fos develop the bone disease osteopetrosis. Fos mutant mice were found to have a block in the differentiation of bone-resorbing osteoclasts that was intrinsic to hematopoietic cells. Bone marrow transplantation rescued the osteopetrosis, and ectopic c-fos expression overcame this differentiation block. The lack of Fos also caused a lineage shift between osteoclasts and macrophages that resulted in increased numbers of bone marrow macrophages. These results identify Fos as a key regulator of osteoclast-macrophage lineage determination in vivo and provide insights into the molecular mechanisms underlying metabolic bone diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939685     DOI: 10.1126/science.7939685

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  319 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

2.  RANKing the importance of measles virus in Paget's disease.

Authors:  F P Ross
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  When developmental biology meets human pathology.

Authors:  G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

4.  RANKing c-Jun in osteoclast development.

Authors:  Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 5.  MicroRNAs and their roles in osteoclast differentiation.

Authors:  Zhuying Xia; Chao Chen; Peng Chen; Hui Xie; Xianghang Luo
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

Review 6.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

7.  TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.

Authors:  Kenta Maruyama; Tatsukata Kawagoe; Takeshi Kondo; Shizuo Akira; Osamu Takeuchi
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 8.  Cellular and molecular mechanisms of bone remodeling.

Authors:  Liza J Raggatt; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

Review 9.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 10.  Role of NF-κB in the skeleton.

Authors:  Deborah Veis Novack
Journal:  Cell Res       Date:  2010-11-16       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.